BRACAnalysis ® is a genetic test that detects the presence of a BRCA1 or BRCA2 gene mutation. BRCAmutations are responsible for the majority of hereditary breast and ovarian cancers. People with a mutation in either the BRCA1 or BRCA2 gene have risks of up to 87 percent for developing breast cancer and 39-63 percent for developing ovarian cancer by age 70. Mutation carriers previously diagnosed with cancer also have a significantly increased risk of developing a second primary cancer. In fact, patients with these types of mutations have an up to 64 percent chance of developing a second breast cancer by age 70.
BRACAnalysis ® requires only a simple blood test or oral rinse sample to determine if a person has a BRCA1 or BRCA2 mutation. Knowing the results may help patients and their healthcare professionals either prevent or delay the onset of cancer or detect it at an earlier, more treatable stage.
Myriad has developed a Hereditary Cancer Quiz that patients and can use to help identify potential candidates for genetic testing using BRACAnalysis ®.Learn More
Our brief and easy-to-use hereditary cancer quiz can help you determine whether you may be a candidate to get tested for several of the most common hereditary cancer syndromes.Get Started
You and your healthcare provider can determine your cancer risk and course of management by understanding your family history and pursuing hereditary cancer testing when appropriate.Get Patient Guide
FAMILY HISTORY TOOL
The Family History Tool starts your pedigree chart with you adding information about yourself, then you’ll be asked for information about family members to complete your health history profile.Get Started
Take this hereditary cancer survivor snapshot to learn if your cancer diagnosis might have been related to an inherited gene mutation. On average, the quiz takes less than 1 minute to complete.Get Started